Press "Enter" to skip to content

Patent delisted for Astellas drug LEXISCAN

0
Copyright © DrugPatentWatch. Originally published at Patent delisted for Astellas drug LEXISCAN

Annual Drug Patent Expirations for LEXISCAN
Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for LEXISCAN.

This drug has eigthy-one patent family members in twenty-six countries.

The generic ingredient in LEXISCAN is regadenoson. One supplier is listed for this compound. Additional details are available on the regadenoson profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at Patent delisted for Astellas drug LEXISCAN
    Do NOT follow this link or you will be banned from the site!